Emmaus Life Sciences Announces Endari® To Be Added to the Florida Medicaid Preferred Drug List

Florida Joins Other States in Eliminating the Need for Prior Authorization for Medicaid Patients TORRANCE, Calif., March 29, 2022 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in the treatment of sickle cell disease, announced today that the Florida Medicaid…